Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Salivary Glands Tumors × Head & Neck × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Head and Neck Neoplasms 1138 Squamous Cell Carcinoma of Head and Neck 617 Thyroid Neoplasms 257 Mouth Neoplasms 159 Breast Neoplasms 154 Neoplasms 153 Carcinoma, Non-Small-Cell Lung 151 Lung Neoplasms 133 Salivary Gland Neoplasms 129 Oropharyngeal Neoplasms 116 Nasopharyngeal Carcinoma 115 Carcinoma, Squamous Cell 104 Colorectal Neoplasms 98 Melanoma 96 Laryngeal Neoplasms 89 Ovarian Neoplasms 87 Esophageal Neoplasms 86 Prostatic Neoplasms 85 Nasopharyngeal Neoplasms 81 Neoplasm Metastasis 78 Pancreatic Neoplasms 77 Stomach Neoplasms 75 Uterine Cervical Neoplasms 71 Thyroid Cancer, Papillary 69 Urinary Bladder Neoplasms 63 Thyroid Nodule 62 Carcinoma, Renal Cell 62 Sarcoma 55 Colonic Neoplasms 55 Tongue Neoplasms 52

Interventions

Abiraterone Acetate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02867852 2021-03-03

SG-ABI14

Fondazione IRCCS Istituto Nazionale dei Tumori, Milano

Phase 2 Completed

Salivary Glands Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡